Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01356576 · ClinicalTrials.gov registry record
Effect of Hemodialysis Membranes on Platelet Count
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 99
- Enrollment target
NCT01356576 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 99 participants.
The verdict
NCT01356576 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there is a drop in platelet count after hemodialysis. Hemodialysis membranes are known to activate complement and cause a drop in platelets and sometimes in white blood cells. The investigators are going to study one of the membranes which is the Fresenius Optiflux® to check if it causes a drop in platelets.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01356576
The ClinicalTrials.gov registry entry for NCT01356576 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01356576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01356576 about?
NCT01356576 is a clinical study titled "Effect of Hemodialysis Membranes on Platelet Count". The purpose of this study is to determine if there is a drop in platelet count after hemodialysis. Hemodialysis membranes are known to activate complement and cause a drop in platelets and sometimes in white blood cells. The investigators are going to study one of the membranes which is the Freseniu...
What is the current status of trial NCT01356576?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2010-09. Estimated completion is 2011-09.
Who is sponsoring clinical trial NCT01356576?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.